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Surnrnary. This study examined the microglial reaction 
in a simulated thrombo-embolus ischaemia in rats given 
an intracarotid injection of a suspension of homologous 
blood clot. Al1 rats including the controls receiving 
vehicle injection were perfused at 5 hours, and 1 , 3  and 7 
days post-operation. The brains were removed and 
processed for immunohistochemistry using a panel of 
monoclonal antibodies: OX-42, OX-18 and OX-6 for 
labeling of microglia. In rats given saline injection OX- 
42 immunoreactive microglial cells were observed to be 
distributed quite evenly throughout the whole brain. 
When injection of clot suspension was given, microglial 
cells responded vigorously, particularly in the ipsilateral 
hippocampus. Microglial reaction was also detected in 
the ipsilateral cerebral cortex, caudate as well as septal 
nuclei. The majority of the detected reactive microglial 
cells were hypertrophied showing thick or  stout 
processes. Some rod-like and amoeboid microglia were 
also observed. Rarely did the reactive microglia express 
OX-6 immunoreactivity. Al1 microglial cells were 
unreactive for OX-18. The actual mechanisms leading to 
the microglial activation as well as functions of reactive 
microglia in focal cerebral ischaemia remain speculative. 
In the absence of direct evidence, it could only be 
suggested that they may act as sensor cells for detection 
of subtle alterations in the microenvironment, probably 
in response to focal ischaemia andlor leakage of serum- 
derived factors induced by thrombo-embolus stroke. 
Key words: Homologous clot,  Foca1 ischaemia, 
Microglial reaction, Brain, Rats 
lntroduction 
Occlusion of large cerebral arteries by electrocautery 
(Wu et al., 1997; Wu and Ling, 1998) and intra-arteria1 
nylon insertion (Zhang et al., 1997b) or ligationt 
clamping (Zivin et al., 1995) have been the experimental 
models of choice for study of focal cerebral ischaemia. 
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Various models of thrombo-embolic induced cerebral 
ischaemia using foreign particles, e.g. intra-arteria1 
injections of microspheres and air (Vise et al., 1977; 
Schuier et al., 1978; Zivin et al., 1995) have also been 
attempted. However, in actual clinical situations, 
cerebral stroke or transient ischaemic attack was most 
commonly caused by thrombo-embolism from vascular 
disease outside the brain (Clarke, 1994; Zivin et al., 
1988). It is most likely that blood clot elements may 
interact with endothelial cells leading to the generation 
of neuro-humoral factors and subsequent pathological 
events (Dietrich et al., 1988). Thus the experimental 
animal model with induced homologous thrombo- 
embolic clot would be closest to the natural cause of 
cerebral vascular disease. In this connection, two 
different approaches have been adopted: 1) photo- 
chemically-induced vascular clot (Watson et al., 1985, 
1987; Futrell et al., 1988; Dietrich et al., 1993); and 2) 
intra-arteria1 injection of homologous or autologous clot 
(Hill et al., 1955; Kudo et al., 1982; Kaneko et al., 1985; 
Zivin et al., 1988; Lyden et al., 1990; Zhang et al., 
1997a). A hallmark of cerebral ischaemia is microglial 
reaction and most observations have been based on 
transient global ischaemic animals induced by four 
vessel occlusion (4-VO) (Morioka et al., 1992;  
Gehrmann et al., 1995; Finsen et al., 1996), a rare 
situation occurring in real life, if at all. Recently, some 
studies have shown microglial activation in focal 
ischaemia using the photochemically induced 
vasculature clot, or by occlusion of the middle cerebral 
artery using nylon or micromanipulator (Lehrmann et 
al., 1997; Zhang et al., 1997b; Schroeter et al., 1999). 
The present study was aimed to study the microglial 
response in transient focal brain ischaemia after intra- 
arteria1 injection of homologous clot. It was hoped that 
the procedure adopted would induce a neuropathological 
scenario closely simulating the likely events ensuing a 
cerebral stroke clinically. A better understanding of 
microglial reaction under such circumstances may 
provide useful information in studying the effects 
of neuroprotective drugs after ischaemia, e.g., 
propentofylline which has been reported to act 
on microglial cells (McRae et al., 1994; Wu et al., 
1999). 
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Materials and methods 
Materials 
A total of 30 Wistar rats weighing between 250- 
300g was used in this study. Of these, 24 of them were 
given an injection of homologous blood clot while the 
remaining 6, which served as the control, received saline 
injection. 
Surgical procedure 
Following deep anaesthesia with an intra-peritoneal 
injection of 7% chloral hydrate (300 mglkg), a midline 
incision was made at the neck. The left external jugular 
vein was then exposed and 20 pl of blood were aspirated 
from it using a 28G syringe needle. The blood was then 
transferred and spread in a Petri dish and left to clot at 
room temperature (25 "C) for 20 minutes. The clot was 
then scraped from the dish and suspended in 40 p l  of 
saline. The clot in saline suspension was then aspirated 
repeatedly for a few minutes with a syringe. The left 
common, external and interna1 carotid arteries were then 
exposed. The external carotid artery just dista1 to the 
bifurcation of the common carotid artery was clamped 
with a vascular clamp. The left common carotid artery 
was then lifted up with a hook before a 30 pl of embolus 
suspension was injected gradually into the arteria1 
circulation using a 28G needle. After the injection, the 
clamp on the external carotid artery was removed. The 
injection site was sealed off with surgicel following the 
withdrawal of needle. The neck incision was then closed 
with silk suture. The rectal temperature was monitored 
and maintained between 37 "C and 38 "C during the 
operation. 
Tetrazolium staining 
Six experimental rats receiving the homologous clot 
injection were killed at 5 hours and 1 day post-injection 
(each interval, n=3) with an overdose of intra-peritoneal 
injection of 7% chloral hydrate. Their brains were 
removed and cleared of al1 the meningeal covering. 
Using a brain sectioning block (Zivic Miller), the 
cerebrum was freshly sectioned into 1 mm thick coronal 
slices which were stained with tetrazolium-blue (TTZ, 
Sigma Co.), as was previously described by Chimon and 
Wong (1998). The stained sections were then fixed in 
4% paraformaldehyde for storage and examined for 
areas of infarct. 
Perfusion and tissue processing 
Rats were sacrificed at 5 hours, 1 , 3  and 7 days (each 
interval, n=6) after intra-carotid injection of clot 
suspension; al1 rats receiving saline injection were killed 
1 day later. They were re-anaesthetized with 7% chloral 
hydrate before being perfused first with Ringer's solution 
followed by an aldehyde fixative composed of a mixture 
of periodate-lysine-paraformaldehyde containing 2% 
paraformaldehyde as described previously (Ng and Ling, 
1997). After perfusion the brain was removed and fixed 
in the same fixative for 2-4 h and was kept in 0.1M 
phosphate buffer containing 15% sucrose overnight at 4 
0- L .  
Serial coronal frozen sections of the entire brain 
were cut at a thickness of 40 pm and incubated in one of 
the following monoclonal antibodies diluted in 1:100 
with phosphate buffered saline: OX-42 (SeraLab, MAS 
370b), OX-18 (SeraLab, MAS 101b) and OX-6 
(SeraLab, MAS 043b) monoclonal antibody for the 
detection of complement type 3 receptor (CR3), major 
histocompability complex (MHC) class 1 and 11 antigens 
on microglia, respectively. After incubation, the sections 
were rinsed in PBS for 15  min and later reacted in 
Vectastain ABC Kit (PK4002, Vector Laboratories, 
Burlingame, CA) against mouse IgG for half an hour in 
a humidified chamber. The sections were then rinsed in 
PBS and treated with a solution of 3-3'-diamino- 
benzidine tetrahydrochloride (DAB, Sigma-5637) and 
hydrogen peroxide (5 mg DAB, 10 m1 PBS, 30 ml 0.3% 
H202). The sections were counterstained with 1% 
methyl green, dehydrated and mounted in Permount. 
A total of 10 sections from each rat was also used 
for conventional histology staining with cresyl fast violet 
or haematoxylin and eosin. 
Physiological variables 
There were no significant differences among 
experimental and control groups in body temperature, 
heart rate or mean systolic or diastolic blood pressure 
monitored before and after injection of homologous clot 
or saline. 
Results 
In sections stained with TTZ, there was no obvious 
macroscopic sign of infarct in rats killed either at 5 hours 
or 1 day after intra-carotid injection of the homologous 
clot. In control rats given saline injection, the ubiquitous 
microglia with fine ramified processes were moderately 
stained with OX-42. There was no noticeable difference 
in microglial immunoreactivity between the two sides of 
the brain. In rats receiving clot suspension injection and 
being killed 1 day later, the following changes were 
observed in 4 of the 6 rats studied: many microglia in the 
cerebral cortex and hippocampus ipsilateral to the 
injection responded vigorously (Figs. la-g, 2a). OX-42- 
immunopositive microglia were distributed throughout 
the cerebral cortex, extending from the brain surface to 
the Corpus callosum (Fig. lb) .  Reactive microglia, 
intensely stained for OX-42, were very much more 
heavily populated at the CA1 and hilar regions in the 
ipsilateral hippocampus (Fig. lg)  when compared with 
the opposite side (Fig. 10. Moderate increase in OX-42- 
immunoreactive microglia was also observed in the 
ipsilateral fornix, anterior commisure, the caudate as 
Flg. l. a and b. Cerebral cortex contralateral (right) (R, Fig. la) and ipsilateral (leít) (L, Fig. 1 b) to the clot injection in a rat, 1 day post-injection. Many 
more OX-42-immunopositive microglia are distributed in the left cerebral cortex extending fom the brain surface to the mrpus callosum (CC). Scale 
bar: 300 pm. c. Higher magnification of OX-42-immunoreactive microglial cells in amoeboid form in the leít cerebral cortex. Scale bar: 100 pm. d. A 
cluster of microglia intensely stained for OX-42 are seen embedded in a mass of amorphous-like substance. The cells are clearly hypertrophied 
compared with those at the periphery. Lefi cerebral cortex. Scale bar: 100 pm. e. Numerous amoeboid OX-42-immunopositive microglia are seen to 
surround what may be a foca1 ischaemic lesion site in the leít cerebral cortex. The lesion, which shows a paler staining compared with the rest of the 
tisues, contains relatively fewer cells. c: capillary. Scale bar: 100 pm. f and g. Coronal sections through the cerebrum showing both the right (R, Fig. 
I f)  and lefl (L, Fig. lg) hippocampus from a rat, 1 day after injection of homologous clot. Large numbers of OX-42-immunoreactive microglial cells are 
localized at the CA1 zone and hilum (H) of the leít hippocampus. Scale bar: 300 pm. 
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well as the septal nuclei (Fig. 2b-d). 
The majority of the OX-42-immunoreactive cells 
had assumed the stage of reactive spiny microglial shape 
in the above-mentioned areas affected by the clot 
suspension injection. Furthermore, many of them were 
hypertrophic bearing thick or stout processes giving 
some of them an amoeboidic appearance (Figs. lc, 2a,d). 
In some areas, the reactive microglial cells appeared to 
transform into elongated rod cells (Fig. 2a). 
An interesting feature after the clot suspension 
injection was the occurrence of clusters of OX-42- 
immunostained cells admixed with an isolated mass of 
amorphous-like substance (Fig. Id). Another striking 
feature was the occurrence of many OX-42-stained 
microglia, delineating what seemed to be foci of 
ischaemia (Fig. le)  which appeared to be more lightly 
stained than the surrounding tissues. 
The above-mentioned microglial alterations, 
however, were not obsewed in rats killed at 5 hours, or 3 
and 7 days after the clot injection. In these animals, the 
distribution of OX-42-immunoreactive microglial 
phenotype was comparable to that in the control rats. 
Except for some immunopositive cells in the 
meninges and choroid plexuses, OX-6-positive cells 
were absent in the control rats. A small number of OX-6- 
positive microglia, however, were observed in the 
ipsilateral cerebral cortex and hippocampus of rats 
sacrificed at 1 day after the blood clot injection (Fig. 2e). 
Occasionally, the long extending microglial processes 
were found to be closely associated with the blood 
vessels or capillaries (Fig. 20.  
Except for the vascular endothelial cells, OX-18- 
immunoreactive cells were undetected in either the 
control or rats receiving the blood clot injection (Fig. 
2g). 
In sections stained with cresyl fast violet or 
haematoxylin and eosin, there was no noticeable 
difference in histological features in the cerebrum 
between the control and experimental sides. Neither was 
there any evidence of neurodegeneration on closer 
examination in areas where reactive microglia were 
prevalent, notably in the ipsilateral hippocampus. 
Discussion 
Studies of microglial reaction following induced 
cerebral ischaemia or infarction have been based 
primarily on global cerebral ischaemia induced by the 4- 
VO method (Schmidt-Kastner et al., 1990; Morioka et 
al., 1992; Jorgensen et al., 1993; Kato et al., 1994, 
1995). The use of nylon monofilament cerebral vascular 
occlusion has also been attempted for the same purpose 
(Zhang et al., 1997b). These methods do not simulate 
actual clinical stroke in human due to thrombo- 
embolism originating from vascular diseases (Clarke, 
1994; Zivin et al., 1988). Blood components of the 
thrombo-embolus, especially platelets may be partially 
responsible for regional cerebral ischaemia. Thus, in 
designing an experimental model for cerebral ischaemia 
al1 this should be taken into consideration. 
The present study has shown that microglial cells 
were activated mainly in the ipsilateral hippocampus. 
This concurs with earlier observations made in global 
cerebral ischaemia (Schmidt-Kastner et al., 1990; 
Morioka et al., 1992; Jorgensen et al., 1993; Kato et al., 
1994, 1995). Along with the above, microglia in the 
cerebral cortex, caudate and septal nuclei as well as 
fornix were also activated by the ischaemic insult. 
It has been reported that microglial activation in 
global cerebral ischaemic brain induced by the 4-VO 
technique occurred in a graded fashion (Schmidt-Kastner 
et al., 1990; Morioka et al., 1992; Jorgensen et al., 1993; 
Kato et al., 1994, 1995; Finsen et al., 1996). Thus, 
microglia were found to express an early and transient 
induction of increased levels of CR3 and MHC class 1 
antigens, followed by a progressive induction of 
leucocyte common antigen (LCA) and ultimately MHC 
class 11 antigen. The  early onset of MHC class 1 
expression and delayed up-regulation of MHC class 11 
antigens were also obsewed in other experimental CNS 
lesions, including nerve sectioning (Streit et al., 1989; 
Rao and Lund, 1989) and kainic acid or 6-hydroxy- 
dopamine injections (Akiyama et al., 1988, 1989). It was 
suggested that the sequential expression of MHC class 1 
antigen followed by that of class 11 antigen was likely to 
reflect a programmed cellular response taken by 
microglia during their activation as a result of neurona1 
damage (Morioka et al., 1992; Kato et al., 1995). The 
expression of MHC antigens in the present study differs 
from that with the 4-VO-induced global cerebral 
ischaemia. Firstly, MHC class 1 antigen was not elicited 
in microglia in our model and, secondly, MHC class 11 
antigen was expressed only in a subgroup of microglia 1 
day after ischaemic induction in the affected areas of the 
brain. Expression of MHC class 11 antigen has also been 
reported 22 hours after focal ischaemia, induced by 
middle cerebral artery occlusion with nylon (Zhang et 
al., 1997b). The present results suggest that it may be 
more difficult to elicit MHC class 1 antigen by ischaemic 
changes induced by injection of thrombo-embolus clot. 
It also raises doubt the hypothesis of programmed 
cellular response leading to sequential expression of 
MHC class 1 and 11 antigens in microglia. The actual 
mechanisms leading to microglial activation and 
induction of MHC antigen expression on microglia in 
focal ischaemia remain uncertain, although it may be 
speculated that vascular damage and leakage of serum- 
derived factors are probably involved. 
The increase in number of microglia after thrombo- 
embolus clot injection may be attributed to proliferation 
of resident microglia as has been shown recently by 
Postler et al. (1997) in human post-infarction brains. 
Postler et al. (1997) have demonstrated an actual 
proliferation of active microglia at the periphery of 
infarction up to day 3 post-infarction. Using liposomes 
containing dichloromethylene diphosphonate, which 
depletes haematogenous rnacrophages, Schroeter et al. 
(1997) showed that the initial phagocytic response after 
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photochemically-induced focal brain ischaemia was an 
intrinsic property of the nervous system mainly 
performed by resident microglia. However, upregulation 
of CR3 in microglia contributing to the numerical 
increase of OX-42-immunoreactive cells following clot- 
injection could not be ruled out. 
Areas considered to be focal ischaemic lesions of 
different sizes were observed in some areas of the CNS. 
As these were absent in control rats, they must be 
attributed to local vascular obstruction caused by the 
injected emboli. Against this is the lack of obvious areas 
of infarct in TTZ-stained sections. A possible 
explanation rnay be that the TTZ staining was not 
sensitive enough to detect microscopic areas of infarct, 
which could have resulted with the present model. In 
sections stained with conventional histology methods, 
such as haematoxylin and eosin as well as the Nissl 
staining, there was no evidence of neuronal degeneration 
in al1 the experimental rats receiving embolus injection. 
This was also true in the ipsilateral hippocampus in 
which OX-42 immunoreactivity which marked the sites 
of CR-3 receptor of microglia was  markedly 
upregulated. The lack of obvious infarct and neuronal 
degeneration in the present model differ from that 
reported by Lehrmann et al. (1997) and Zhang et al. 
(1997a). The discrepancy rnay be attributed to different 
methods used to induce the focal cerebral ischaemia. 
Lehrmann et al. (1997) had used micromanipulator to 
block the middle cerebral artery, while Zhang et al. 
(1997a) had injected the blood clot directly into the 
middle cerebral artery via a catheter. Al1 these could 
have caused a more severe blockage of perfusion or 
ischaemia to a vast area of the brain resulting in drastic 
neurodegeneration. 
A feature worthy of note in this study was the 
occurrence of clusters of activated microglia delineating 
the ischaemic lesion. It is suggested that they rnay 
function to protect the surrounding normal neurons from 
potential adverse factors that rnay be released from the 
ischaemic neurons affected by the clot injection. This is 
because neurons in ischaemic brain induced by middle 
cerebral artery occlusion have been shown to release 
excitatory amino acids such as glutamate and activation 
of N-methyl-D-aspartate (Rothman and Olncy, 1987; 
Collaco et al., 1994). The  latter were linked to 
dysfunction in energy metabolism, which would 
eventually result in calcium overloading in neurons 
(Dienel, 1984; Choi, 1988). 
The functional significance of microglial response in 
simulated thrombo-embolus-induced brain ischaemia 
remains unclear. Activated microglia are believed to 
aggravate degeneration in various CNS pathologies and 
experimental lesions, by secreting neurotoxic substances 
including oxygen radicals, nitrous oxide, glutamate and 
even microglia-derived tissue plasminogen activator 
(Colton and Gilbert, 1987; Piani et al., 1991; Zielasek et 
al., 1992; Giulian et al., 1993; Rogove and Tsirka, 1998). 
On the other hand, cytokines like interleukin-lB and 
transforming growth factor (TGF)-B1 are produced in 
both focal as well as global cerebral ischaemic brains 
(Wiessner et al., 1993; Buttini et al., 1994; Lehrmann et 
al., 1995; Finsen et al., 1996). Much of the TGF-í31 
found in the ischaemic brains has been shown to be 
produced by activated microglia in areas of cerebral 
ischaemia. TGF-B1 is known to deactivate macrophages 
(Tsunawaki et al., 1988), suppress microglial 
cytotoxicity (Merill and Zimmerman, 1991), and act as 
an immunosuppressive molecule (Ruscetti and Palladino, 
1991). Recent evidence also shows that microglia can 
secrete trophic factors such as glial cell-line derived 
neurotrophic factor, brain-derived neurotrophic factors 
and the potent dopaminergic neurotrophic factor in the 
injured striatum (Batchelor et al., 1999). In the light of 
the above findings, it is suggested that the reactive 
microglia induced by the clot injection rnay be involved 
in similar functions but probably more in neuronal 
protection. This takes into consideration the fact that 
there was no obvious sign of cell death at various time 
intervals after the clot injection. It is noteworthy .that 
while microglial reaction was drastically induced in rats 
killed at 1 day, it readily subsided in longer surviving 
rats killed at 3 and 7 days. It is suggested that the 
injected homologous clot could have been degraded, and 
hence, the ischaemic damage was only of transient 
nature. Another possibility rnay be that the microglial 
reaction had helped to restore and prevent further 
harmful damage resulting from the ischaemic insult 
induced by the clot injection. 
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